Syngene Reports FY26 Revenue Rise And Board Changes

05 May 2026 CW Team

Net cash generated during the year was Rs. 5,210 mn after capital expenditure. Operating EBITDA for the year was Rs. 9,180 mn, down from Rs. 10,420 mn in the prior year, reflecting margin pressure. The results excluded a gratuity re-measurement credit of Rs. 200 mn and termination benefits of Rs. 250 mn recognised as exceptional. Management also disclosed an insurance settlement of Rs. 210 mn and an increase in gratuity liabilities of Rs. 380 mn.

The board confirmed several leadership changes. Kiran Mazumdar-Shaw became Executive Chairperson effective April 1, 2026 for a five-year term and Siddharth Mittal will take over as Managing Director and Chief Executive Officer effective July 1, 2026 for a five-year term. The board recommended Vijaya Chandru and Arun Chandavarkar as independent directors and reappointed Vinita Bali for one year. Maninder Kapoor Puri and Abhijit Zutshi join as Chief Human Resources Officer and Chief Commercial Officer respectively.

Syngene said it is expanding capabilities in antibody-drug conjugates and has commenced operations at an ADC discovery laboratory and a GMP bioconjugation suite to support discovery through manufacturing. The company completed 14 client and regulatory audits in the quarter and obtained GCP-NABL accreditation. An investor call was scheduled for 2 pm IST on April 30, 2026; replay is available until May 07, 2026 and a transcript will be posted within seven working days. The company serves global customers with over 8,300 employees and 3 mn sq. ft of specialised facilities.

Bengaluru, April 29, 2026: Syngene International Limited (Syngene) reported fourth quarter and full-year results for fiscal year 2026. Full-year revenue from operations rose three per cent to Rs. 37,390 mn and fourth quarter revenue rose two per cent year-on-year to Rs. 10,370 mn, up 13 per cent sequentially. Operating EBITDA margin for the quarter was 29 per cent and for the year 25 per cent. Profit after tax before exceptional items was Rs. 1,530 mn in the quarter and Rs. 3,800 mn for the year. Net cash generated during the year was Rs. 5,210 mn after capital expenditure. Operating EBITDA for the year was Rs. 9,180 mn, down from Rs. 10,420 mn in the prior year, reflecting margin pressure. The results excluded a gratuity re-measurement credit of Rs. 200 mn and termination benefits of Rs. 250 mn recognised as exceptional. Management also disclosed an insurance settlement of Rs. 210 mn and an increase in gratuity liabilities of Rs. 380 mn. The board confirmed several leadership changes. Kiran Mazumdar-Shaw became Executive Chairperson effective April 1, 2026 for a five-year term and Siddharth Mittal will take over as Managing Director and Chief Executive Officer effective July 1, 2026 for a five-year term. The board recommended Vijaya Chandru and Arun Chandavarkar as independent directors and reappointed Vinita Bali for one year. Maninder Kapoor Puri and Abhijit Zutshi join as Chief Human Resources Officer and Chief Commercial Officer respectively. Syngene said it is expanding capabilities in antibody-drug conjugates and has commenced operations at an ADC discovery laboratory and a GMP bioconjugation suite to support discovery through manufacturing. The company completed 14 client and regulatory audits in the quarter and obtained GCP-NABL accreditation. An investor call was scheduled for 2 pm IST on April 30, 2026; replay is available until May 07, 2026 and a transcript will be posted within seven working days. The company serves global customers with over 8,300 employees and 3 mn sq. ft of specialised facilities.

Infrastructure Transport

25 May 2026

RAHSTA Awards 2026 Opens Nominations for Smart Road Innovations

RAHSTA Awards 2026 has announced nominations for the Materials and Technology categories, recognising the innovations reshaping India’s road and highway infrastructure sector.With growing emphasis on sustainability, durability, digitalisation and safety, modern road infrastructure increasingly relies on advanced materials and intelligent technologies. The awards aim to celebrate organisations developing next-generation solutions for road construction, pavement performance, digital project management and smart mobility.The awards will be presented during RAHSTA 2026, scheduled on July 8–9, ..

Infrastructure Urban

25 May 2026

Top 10 Mega Infrastructure Projects in India (2026)

India is undergoing one of the largest infrastructure transformations in the world, with massive investments being channelled into highways, railways, urban transit, ports, and smart cities. These mega infrastructure projects in India are not only improving connectivity but also boosting economic growth, creating jobs, and attracting global investments.In 2026, the focus is on building world-class infrastructure that is faster, more sustainable, and technologically advanced. From expressways and bullet trains to smart cities and industrial corridors, these projects are shaping the future of In..

Equipment

25 May 2026

MANN+HUMMEL Opens Tumkur Innovation Centre

MANN+HUMMEL, a global leader in filtration solutions, today announced the launch of its new state-of-the-art Global Technology & Innovation Center in Tumkur, Karnataka, marking a significant milestone in its global growth strategy. Positioned as MANN+HUMMEL’s largest development center outside Germany, the facility reinforces India’s role as a critical hub for engineering, innovation, and advanced filtration technologies.The Tumkur facility is designed to accelerate global product development and customer-centric innovation by integrating advanced research labs, testing infrastructure,..